Repligen Corporation engages in the development and commercialization of bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, scale down validation of chromatography processes, and ELISA test kits. The company also provides filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Repligen Corporation

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Repligen (RGEN – Research Report) and Definium Thera...

Analysts Are Bullish on These Healthcare Stocks: Repligen (RGEN), Definium Therapeutics (DFTX)

Delta Cleantech ( ($TSE:RGEN) ) has provided an update. Regenera Insights Inc. has announced the resignation of director Steve Olasz and the appoin...

Regenera Refreshes Board with Appointment of Independent Director Douglas Whitehead

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Repligen (RGEN – Research Report) and NeoGenomics (N...

Wall Street Analysts Are Bullish on Top Healthcare Picks

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Day One Biopharmaceuticals (DAWN – Research Report),...

Analysts Offer Insights on Healthcare Companies: Day One Biopharmaceuticals (DAWN), Tenet Healthcare (THC) and Repligen (RGEN)

Repligen ( ($RGEN) ) has provided an update. On January 6, 2026, Repligen Corporation announced that its board has elected independent director Dr....

Market Cap	$8.18B	P/E Ratio	91.04
52W High	$175.77	52W Low	$102.97
Div Yield	N/A	Payout Ratio	0.0%
EPS Growth 3Y	-30.0%	52W Position	66.1%
Overall Score	48	Value Score	40
Quality Score	50	Technical Score	54

EPS Current Est	$1.66	EPS Next Est	$2.06
EPS Growth Est	+24.1%	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	RGEN	$151.12	+1.17%	591.65K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	RGEN	$151.12	+1.2%	591.65K
3
4
5
6

RGEN

RGEN

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Repligen Corporation Data in Excel

Get Repligen Corporation Data in Excel